MedTrace Logo

The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users

NCT03264781 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2017-08-30

No results posted yet for this study

Summary

The purpose of this study is to determine that once-a-month injectable contraceptive( Cyclofem® ) has the effect on treatment of irregular uterine bleeding in implant contraceptive users or not.

Conditions

  • Uterine Bleeding

Interventions

DRUG

Cyclofem

Intramuscularly injection 0.5 ml of Cyclofem or placebo

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Nitisa Tapanwong, MD · Department of Obstetrics and Gynecology of King Chulalongkorn Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264781 on ClinicalTrials.gov